MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) announced today the introduction of the ACQUITY™ UPLC PLUS Series, three new ACQUITY UltraPerformance LC™ (UPLC™) Systems that build off ...

“The scientific discoveries with the biggest potential to improve our lives often rely on samples and compounds that are the most difficult to understand. The ACQUITY UPLC I-Class System was designed ...

ACQUITY™ Premier UPLC™ System: The next evolution in separation science is here. Maximizing the sensitivity, repeatability, and robustness of your LC and LC-MS applications is critical. The ACQUITY ...

The ACQUITY UPLC I-Class PLUS System offers industry-leading separations performance, opening up new possibilities for maximizing the resolution and sensitivity of your methods, improving the ...

Waters Corporation's ( WAT) ACQUITY UPLC TQD system has been approved as a medical device by the Chinese Food and Drug Administration and can now be legally promoted and sold in China. This device ...

The ACQUITY UPLC? H-Class System combines the chromatographic performance of UPLC? with the solvent blending flexibility of quaternary. There's an ACQUITY system for every lab. In 2004, ACQUITY UPLC ® ...

The system was approved for clinical analysis of a variety of compounds that include diagnostic indicators and compounds for treatment monitoring The Chinese Food and Drug Administration (CFDA) has ...

Pre-recorded webinar available for immediate playback. Traditional method development, in which an LC method is developed principally by trial-and-error, is time consuming and may not result in a ...

Ernie Hillier from Waters shows us their Acquity Patrol Laboratory Analyzer. It is a walk-up system that uses UPLC, liquid chromatography technology and is suited to such things as process development ...

As analytical technology continues to advance, both regulatory agencies and pharmaceutical companies are keen to avail themselves of these enhancements. In the case of chromatography, evolution from ...